ContraFect Corporation announced that the company's Chief Executive Officer, Julia P. Gregory, plans to retire. Steven C. Gilman, PhD, the company's Chairman, will serve as Chairman and Interim Chief Executive Officer, effective March 21, 2016, until a new Chief Executive Officer is appointed. Dr. Gilman joined the ContraFect Board as Executive Chairman in June 2015 after a distinguished career in the pharmaceutical industry, most recently as the Executive Vice President and Chief Scientific Officer at Cubist Pharmaceuticals Inc. Prior to Cubist, he was Chairman and Chief Executive Officer of ActivBiotics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 USD | -3.23% | -25.74% | -50.00% |
05-03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
04-26 | North American Morning Briefing : Tech Still in -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 166K | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- CFRXQ Stock
- News ContraFect Corporation
- ContraFect Corporation Announces Executive Changes